Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CLASP2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CLASP2 mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of CLASP2 mRNA | decreases expression | 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLASP2 mRNA | decreases expression | 19150397
|
D004958 |
Estradiol |
Estradiol affects the expression of CLASP2 mRNA | affects expression | 14699072
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CLASP2 mRNA | affects cotreatment|increases expression | 17183730
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of CLASP2 mRNA | increases expression | 16807920
|
D008628 |
Mercury |
Mercury results in increased expression of CLASP2 mRNA | increases expression | 16823088
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of CLASP2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.77 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.43 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.43 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.36 | 17497416 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.36 | 18985861 19232924 18316065 18396377 15238991 19460635 18558336 17688650 18775368 17507914 20603192 18940202 18177632 17157402 16609825 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
5.13 | 16634805 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.52 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.04 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.04 | 12948864 17261762 14630087 17018787 17289903 16675129 19861407 18497071 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.71 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.51 | 10334427 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.98 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.98 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.98 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.77 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.77 | 18551238 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
4.05 | 16823706 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.56 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.56 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.56 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.11 | 11473722 18566989 19148513 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.50 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.50 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.50 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 8888407 18558336 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.75 | 20471113 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.88 | 16612254 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.09 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.75 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
6.75 | 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.42 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.42 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
13.42 | 15610895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14716833 14659978 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.71 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.71 | 21137059 20195826 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.66 | 2876784 2876786 6135515 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.58 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20135361 20064080 17053015 18569708 18520028 20869020 6695378 20464547 18816296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.68 | 16891317 17203775 11807958 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.44 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.32 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.32 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.25 | 11141357 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.89 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.54 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.54 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.27 | 19401270 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.11 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.06 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.06 | 16740699 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
10.62 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
10.62 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
10.62 | 11044598 17978042 1511512 11738929 3137016 15475178 16876388 14763951 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.45 | 10029692 19755658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.68 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.68 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.68 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.96 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.96 | 10091137 |